Genetic Testing at Prostate Cancer Diagnosis and Monitoring May Lead to Better Treatments

Genetic Testing at Prostate Cancer Diagnosis and Monitoring May Lead to Better Treatments
Patients with prostate cancer should be monitored for genetic changes not only at the time of diagnosis but also during treatment as the disease progresses, according to Prof. Tapio Visakorpi from the University of Tampere in Finland. Knowing the genetic landscape of patients will lead to more tailored treatments, ultimately improving patient’s outcomes, he said. “Most

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , .

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

Leave a Comment

Your email address will not be published. Required fields are marked *